Code Bio Competitors and Similar CompaniesClear all

Code Bio's competitors and similar companies include Arrowhead Pharmaceuticals, GEROPHARM, ActiveSite Pharmaceuticals and uniQure.

	Code Bio Code Bio is a company developing transformational, non-viral, genetic medicines to treat and potentially cure serious and life-threatening diseases.	Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals is a biopharmaceutical company that specializes in drug development.	GEROPHARM GEROPHARM is a pharmaceutical company developing gene-engineering human insulins.	ActiveSite Pharmaceuticals ActiveSite Pharmaceuticals is a company engaged in discovering small molecule drug candidates for human diseases with unmet medical needs.	uniQure uniQure is a company that provides gene therapy solutions.
Founding Date	Founding Date 2020	Founding Date 2001	Founding Date 2001	Founding Date N/A	Founding Date 1998
Type	Type Private	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare diabetes drug development genetics life sciences platform	Tags Healthcare biotech drug development therapy	Tags Healthcare diabetes drug development genetics pharma	Tags Healthcare biotech diabetes drug development life sciences pharma	Tags Healthcare biotech drug development genetics life sciences
Locations	Locations Hatfield, US HQ	Locations Pasadena, US HQ Madison, US San Diego, US	Locations Sankt-Peterburg, RU HQ Baku, AZ T'bilisi, GE Almaty, KZ Melezha, RU Moskva, RU Obolensk, RU see more	Locations HQ	Locations Amsterdam, NL HQ Allschwil, CH Lexington, US Lexington, US Lexington, US
Employees	Employees 2912% decrease	Employees 13416% increase	Employees 1721% increase	Employees N/A	Employees 209
Valuation ($)	Valuation ($) N/A	Valuation ($) 2.5 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 312.6 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $829.4m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $16.1m (FY, 2025)
Net income	Net income N/A	Net income $30.1m (FY, 2025)	Net income N/A	Net income N/A	Net income ($199m) (FY, 2025)
Operating ⚠
Facilities	Facilities N/A	Facilities 2 (FY, 2016)	Facilities N/A	Facilities N/A	Facilities 5 (FY, 2022)
Funding
Total funding raised	Total funding raised $ 85m	Total funding raised $ 147.1m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 78m